Filler, Bone Void, Recombinant Platelet-Derived Growth Factor
OYR is the FDA product code for Filler, Bone Void, Recombinant Platelet-Derived Growth Factor. FDA's definition for this code reads: "For use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- OYR
- Device name
- Filler, Bone Void, Recombinant Platelet-Derived Growth Factor
- FDA definition
- For use as an alternative to autograft in hindfoot and ankle fusion procedures that require supplemental graft material, including tibiotalar, tibiocalcaneal, talonavicular and calcaneocuboid fusions.
- Device class
- Not classified
- Review panel
- Unknown
- Submission type
- Contact ODE
- Implant
- Yes
- Life sustaining or supporting
- Yes
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code OYR.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
